RE:RE:RE:RE:RE:RE:RE:RE:Market News & Research Alert from TD" i personally have a (hard? - ed) time believing that in the corporate world with a BOD to answer to that a company can anti promote to this extent without an ulterior motive....companies don't just throw money at every little project with potential. ... i personally believe that there is an end game to the 20 years ..." - AF
Well put ...
If without much potential, it's not something that would attract Baxter's time, energy and money (chump change as it may be for them). The end-game has yet to be revealed...and when it is, it most likely will reveal (in hindsight) the rationale for an almost complete lack of interim promo (and some would even say an anti-promo campaign).
And while I have thought this before (and been wrong), in the grand scheme (and a 20 year horizon), the end-game is nigh.
At least of late, say in the past two years or so, it has morphed into a multi-trick pony (e.g. adding CRRT, home dialysis, and a likely Covid-19 treatment). And the financing risk (funding of Trial completion) has been substantially reduced/ put to bed. Those two factors alone should have doubled or tripled the price if the market was truly paying attention (which clearly they are not).
MM